IMPLANTABLE VOLTAIC CELL

• US 20100004521A1
• Filed: 05/07/2007
• Published: 01/07/2010
• Est. Priority Date: 05/05/2006
• Status: Abandoned Application

• Current Assignee: Spencer J.G. Epps
• Original Assignee: Spencer J.G. Epps
• Inventors: Epps, Spencer J.G.
• Application Number:
  US12/299,752
• Publication Number:
  US 20100004521A1
• Time in Patent Office: Days
• US Class Current: 600/347
• CPC Class Codes: A61B 2560/0214 of power generation or supply
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: H01M 8/16 Biochemical fuel cells, i.e. cells in which microorganisms function as catalysts
• CPC Class Codes: Y02E 60/50 Fuel cells

Abstract

The invention provides a voltaic cell for implantation into the body of a subject that oxidizes oxidizable biological material to generate current to do work. The voltaic cell comprises a biologically inert shell having an inner compartment containing a cathodic environment and an anodic environment on the outer surface of the shell that is in contact with bodily fluid. A connector connects the anodic environment to the cathodic environment and has a component that provides resistance between the anodic and cathodic environments. The shell contains at least one salt bridge disposed within the shell that permits passage of small ions between the inner compartment and the bodily fluid, thereby completing the circuit. The invention also provides devices such as a glucometer which continuously detects glucose and transmits a signal to an external device which provides an output, such as blood glucose level. Methods of using the same are also provided.

Claims

1. A voltaic cell for use in the body of a subject comprising:

a biologically inert shell defining an inner compartment, said inner compartment containing an ionic solution that mediates a reduction reaction, said shell having an inner surface and an outer surface, said inner surface being in contact with said ionic solution;

a cathodic environment within said shell in contact with said ionic solution;

an anodic environment attached to said outer surface of said shell, in contact with bodily fluid wherein said anode accepts electrons from an oxidation reaction with at least one oxidizable biological material in said bodily fluid;

a connector connecting said anodic environment and said cathodic environment;

a component that provides resistance disposed along said connector between said anode and said cathode; and

at least one salt bridge disposed within said shell permitting passage of ions between said inner compartment and said bodily fluid.

2. The voltaic cell of claim 1 wherein said cathodic environment comprises at least one cathode.

3. The voltaic cell of claim 1 wherein said anodic environment comprises at least one anode.

4. The voltaic cell of claim 2 wherein said anodic environment comprises at least one anode.

5. The voltaic cell of claim 1 wherein said oxidizable biological material is selected from the group consisting of carbohydrates, cholesterols, fatty acids, amino acids, polypeptides, lipids, hormones and polynucleotides.

6. The voltaic cell of claim 5 wherein said carbohydrate is glucose.

7. The voltaic cell of claim 5 wherein said hormone is selected from the group consisting of estrogen, progesterone, testosterone, growth hormone and thyroid hormone.

9. The voltaic cell of claim 1 wherein said ionic solution comprises diamminesilver complex [Ag(NH₃)₂]⁺, silver, copper, or iron salts

10. The voltaic cell of claim 1 wherein said voltaic cell comprises a plurality of cathodes.

11. The voltaic cell of claim 1 wherein said voltaic cell comprises a plurality of anodes.

12. The voltaic cell of claim 11 wherein said voltaic cell comprises a plurality of cathodes.

13. The voltaic cell of claim 1 wherein said shell comprises a plurality of salt bridges.

14. The voltaic cell-of claim 1 wherein said connector is a wire.

15. The voltaic cell of claim 1 wherein said cathode is a non-magnetic metal.

16. The voltaic cell of claim 2 wherein said cathode is selected from the group consisting of silver, aluminum, lead, magnesium, platinum, gold, tin oxide, titanium dioxide, tungsten, non-magnetic alloys, semiconductors, semimetals and organometallic complexes.

17. The voltaic cell of claim 1 wherein said shell is formed from an impermeable material.

18. The voltaic cell of claim 1 wherein said shell is formed from a semi-permeable material.

19. The voltaic cell of claim 1 further comprising an inert barrier having selective permeability to exclude bio-fouling molecules wherein said barrier covers said anode.

20. The voltaic cell of claim 19 wherein said barrier comprises a layer that covers said outer surface of said shell.

21. The voltaic cell of claim 1 wherein said component that provides resistance is selected from the group consisting of a microradio or microprocessor.

22. The voltaic cell of claim 3 wherein said anode is complexed with ammonia (NH₃) molecules.

23. The voltaic cell of claim 3 wherein said anode comprises an enzyme that oxidizes said oxidizable biological material.

24. The voltaic cell of claim 18 wherein said enzyme is selected from the group consisting of glucose oxidase, cholesterol oxidase, hexose oxidase, 1-amino acid oxidase, D-amino acid oxidase, uricase, lactate oxidase, choline oxidase, alcohol oxidase, uricase, xanthine oxidase, bilirubin oxidase, glutamate oxidase, and polyamine oxidase.

25. The voltaic cell of claim 1 further comprising a metabolic environment disposed on the outer surface of said shell or layered over said anodic environment wherein said metabolic environment comprises a plurality of metabolic enzymes and cofactors that oxidize a plurality of oxidizable biological materials.

26. The voltaic cell of claim 25 wherein said metabolic environment comprises metabolic enzymes and cofactors selected from the group consisting of oxidoreductases, transferases, hydrolases, lyases, isomerases, ligases, coenzymes, cofactors, and prosthetic groups.

27. The voltaic cell of claim 26 wherein said plurality of metabolic enzymes and cofactors comprise oxidases, reductases, dehydrogenases, synthases, citric acid cycle enzymes, NAD⁺/NADH, FMN/FMNH₂, NADH dehydrogenase, FAD/IFADH₂, fumarate/succinate, succinate dehydrogenase, acyl CoA dehydrogenase, ubiquinone.

28. The voltaic cell of claim 27 wherein said cathodic environment comprises cytochromes b, c, and a+a₃, iron-containing porphyrin, and ubiquinone.

29. The voltaic cell of claim 25 wherein a single layer comprises said metabolic environment and said anodic environment.

30. The voltaic cell of claim 25 wherein said metabolic environment is disposed in a layer on an outer portion of said anodic environment and is in contact with said bodily fluid, wherein said anodic environment is separated from said metabolic environment by an impermeable boundary layer, wherein said boundary layer comprises gated channels that are operably connected to receptors for an analyte, said receptors extending from said channels to said bodily fluid, wherein binding of said analyte to said receptor causes said channels to open and permit flow electrons to anodic environment.

31. The voltaic cell of claim 28 wherein said anodic environment comprises a impermeable boundary layer between said anodic environment and said bodily fluid, wherein said boundary layer comprises gated channels that are operably connected to receptors for an analyte, said receptors extending from said channels to said bodily fluid, wherein binding of said analyte to said receptor causes said channels to open and permit flow of said oxidizable biological material into said anodic environment.

55. A method of powering an implantable medical device comprising connecting said device to at least on voltaic cell of claim 1.

56. The method of claim 55 wherein a plurality of voltaic cells is provided in parallel.

8. The voltaic cell of claim S wherein said polypeptide is prostate-specific antigen or a cancer-specific polypeptide.

32. An implantable glucometer comprising a first component and a second component, said first component comprising:

a biologically inert, shell defining an inner compartment, said inner compartment containing an ionic solution that mediates a reduction reaction, said shell having an inner surface and an outer surface, said inner surface being in contact with said ionic solution;

a cathodic environment within said shell in contact with said ionic solution;

an anodic environment on said outer surface of said shell, in contact with bodily fluid wherein said anodic environment accepts electrons from an oxidation reaction of glucose in said bodily fluid;

a connector connecting said anodic environment and said cathodic environment;

a component that provides resistance disposed along said connector between said anodic environment and said cathodic environment; and

at least one salt bridge disposed within said shell connecting said inner compartment and an outside portion of said shell;

said second component comprising a detection device, wherein said detection device detects a signal from said first device and provides a value that correlates with blood glucose level in said subject.

33. The glucometer of claim 32 wherein said cathodic environment comprises at least one cathode.

34. The glucometer of claim 32 wherein said anodic environment comprises at least one anode.

35. The glucometer of claim 34 wherein said cathodic environment comprises at least one cathode.

36. The glucometer of claim 32 wherein said second component is an amperemeter.

37. The glucometer of claim 32 wherein said component that provides resistance is a microradio or microprocessor.

38. The glucometer of claim 32 further comprising an inert barrier layer having selective permeability for small ions covering said anode.

39. The glucometer of claim 32 wherein said anodic environment comprises glucose oxidase.

40. The glucometer of claim 39 wherein said glucose oxidase is complexed with at least one anode.

41. The glucometer of claim 32 wherein said anodic environment comprises ammonia.

42. The glucometer of claim 41 wherein said ammonia is complexed with at least one anode.

43. The glucometer of claim 32 wherein said ionic solution comprises diamminesilver complex [Ag(NH₃)₂]⁺, silver, copper or iron salts.

44. The glucometer of claim 32 wherein said shell comprises a plurality of salt bridges.

45. The glucometer of claim 32 wherein said connector is a wire.

46. The glucometer of claim 33 wherein said cathode is a non-magnetic metal.

47. The glucometer of claim 33 wherein said cathode is selected from the group consisting of silver, aluminum, lead, magnesium, platinum, gold, tin oxide, titanium dioxide, tungsten, non-magnetic alloys, semiconductors, semimetals and organometallic complexes.

48. The glucometer of claim 32 wherein said shell is formed from an impermeable material.

49. The glucometer of claim 32 wherein said shell is formed from a semi-permeable material.

50. The glucometer of claim 32 further comprising an inert barrier having selective permeability to exclude bio-fouling molecules wherein said barrier covers said anode.

51. The glucometer of claim 50 wherein said barrier comprises a layer that covers said outer surface of said shell.

52. A method of measuring blood glucose comprising:

implanting a first device in the body of a subject such that said first device is in contact with blood;

allowing said first device to contact glucose in said blood whereby oxidation of glucose contacting said first device initiates an electric current in said first device; and

detecting said current with a second device;

wherein said first device comprises a glucometer of claim 32; and

wherein said second device detects current and provides an indication of blood glucose level in said subject.

53. The method of claim 52 wherein said second device is an amperemeter.

54. The method of claim 52 wherein said component that provides resistance is a radio emitter and said second device is a radio receiver.

57. A voltaic cell for use in the body of a subject comprising:

a biologically inert shell defining an inner compartment, said inner compartment containing a solution that mediates an oxidation reaction, said shell having an inner surface and an outer surface, said inner surface being in contact with said solution;

an anodic environment within said shell wherein said anodic environment comprises electron donors, antioxidants or active reductants;

a cathodic environment on said outer surface of said shell, in contact with bodily fluid;

a connector connecting said anodic environment and said cathodic environment;

a component that provides resistance disposed along said connector between said anode and said cathode; and

at least one salt bridge disposed within said shell permitting passage of ions between said inner compartment and said bodily fluid.

58. The voltaic cell of claim 57 wherein said electron donors comprise NADH, FADH₂, and FMNH₂.

59. The voltaic cell of claim 57 wherein said antioxidants comprise glutathione or ascorbate.

60. The voltaic cell of claim 57 wherein said active reductants comprise sodium borohydride.